-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – SP-420 in Beta Thalassaemia
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. SP-420 in Beta Thalassaemia Drug Details: SP-420 is under development for the treatment of transfusion...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – SP-624 in Schizophrenia
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SP-624 in Schizophrenia Drug Details: SP-624 is under development for the treatment of major...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – SP-101 in Cystic Fibrosis
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. SP-101 in Cystic Fibrosis Drug Details: SP-101 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – SP-16 in Myocardial Infarction
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. SP-16 in Myocardial Infarction Drug Details: SP-16 is under development for the treatment of type...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – SP-624 in Major Depressive Disorder
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. SP-624 in Major Depressive Disorder Drug Details: SP-624 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – SP-0125 in Respiratory Syncytial Virus (RSV) Infections
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.SP-0125 in Respiratory Syncytial Virus (RSV) InfectionsDrug Details:SP-0125 is under development for the prevention of respiratory...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – SP-0274 in Respiratory Syncytial Virus (RSV) Infections
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.SP-0274 in Respiratory Syncytial Virus (RSV) Infections Drug Details:SP-0274Â is under development for the prevention of respiratory...
-
Product Insights
![]()
SP Chemicals (Taixing) Company Taixing Complex, China
SP Chemicals (Taixing) Company Taixing Complex is located in Jiangsu, China. The petrochemicals complex is owned by SP Chemicals Holdings Ltd. It is operated by SP Chemicals (Taixing) Co Ltd. The project started its operations in 1998. SP Chemicals (Taixing) Company Taixing Complex profile includes core details such as complex name, location, complex status, start year, annual petrochemical capacity (mtpa) for the period 2015-2030, key feedstock, key products produced, operator, technology, key products capacity and capacity share of the total...
-
Sector Analysis
New![]()
Poland Biopower Market Analysis by Size, Installed Capacity, Power Generation, Regulations, Key Players and Forecast to 2035
Poland Biopower Market Report Overview The cumulative installed capacity for biopower in Poland was 1,754.9 MW in 2022. It is expected to grow at a CAGR of more than 2% during 2022-2035. The Poland biopower market research report offers comprehensive information and an understanding of the biopower market in Poland. The report discusses the renewable power market in the country and provides forecasts up to 2035. Poland Biopower Market Outlook 2022-2035 (MW) Buy Full Report for More Insights on the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Seclidemstat Mesylate in Myelodysplastic Syndrome
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Seclidemstat Mesylate in Myelodysplastic Syndrome Drug Details: Seclidemstat (SP-2577) is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Seclidemstat Mesylate in Chronic Myelomonocytic Leukemia (CMML)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Seclidemstat Mesylate in Chronic Myelomonocytic Leukemia (CMML) Drug Details: Seclidemstat (SP-2577) is under development for...
-
Case Studies
![]()
Non-Alcoholic Beverages Packaging Opportunities – New Packaging Formats and Value-added Features
Category Packaging Opportunities: Non-Alcoholic Beverages explores new packaging formats and value-added features in the non-alcoholic beverages categories, using examples from GlobalData's Pack-Track innovation tool. With a huge and varied range of products on the retail shelf, it can be difficult for brand owners to offer something unique to consumers. Packaging is a key element that can provide differentiation and important added-value benefits. By using packaging to improve convenience and functionality it is possible to adapt to changing consumer lifestyles. Packaging...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – KL4 Surfactant in Acute Lung Injury
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.KL4 Surfactant in Acute Lung InjuryDrug Details:Synthetic peptides are under development for the treatment of acute...
-
Sector Analysis
![]()
Poland Construction Market Size, Trend Analysis by Sector, Competitive Landscape and Forecast, 2023-2027
Poland Construction Market Report Overview The Poland construction market size was $136.9 billion in 2022. The market is projected to achieve an AAGR of more than 2% during 2024-2027. The industry’s output over the long term will be supported by investments in renewable energy projects in line with the government’s target to have zero-emissions sources account for a majority of the installed capacity by 2040. Poland Construction Market Outlook, 2022-2027 ($ Billion) Buy Full Report to Know More about the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Zelpultide alfa in Bronchopulmonary Dysplasia
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Zelpultide alfa in Bronchopulmonary DysplasiaDrug Details:AT-100 is under development for the treatment of bronchopulmonary dysplasia (BPD),...
-
Product Insights
![]()
Virako Sp zoo – Monopolis Commercial Complex – Lodz Voivodeship
Equip yourself with the essential tools needed to make informed and profitable decisions with our Virako Sp zoo - Monopolis Commercial Complex - Lodz Voivodeship report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
![]()
SPS – Purulia Sponge Iron Plant Expansion – West Bengal
Equip yourself with the essential tools needed to make informed and profitable decisions with our SPS - Purulia Sponge Iron Plant Expansion - West Bengal report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ivaltinostat in Pancreatic Ductal Adenocarcinoma
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Ivaltinostat in Pancreatic Ductal Adenocarcinoma Drug Details: Ivaltinostat is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – PVX-410 in Triple-Negative Breast Cancer (TNBC)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.PVX-410 in Triple-Negative Breast Cancer (TNBC) Drug Details:PVX-410 is under development for the treatment of smoldering...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Luxeptinib in Relapsed Chronic Lymphocytic Leukemia (CLL)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Luxeptinib in Relapsed Chronic Lymphocytic Leukemia (CLL) Drug Details: CG-806 is under development for...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.